Method for measuring MRE11 in tissues to predict cystectomy or bladder sparing surgery plus chemoradiation therapy
Abstract:
A method of identifying cancer patients who would be responsive to bladder sparing surgery plus chemoradiation therapy or cystectomy using expression of MRE11 in a nuclear to cytoplasmic ratio is presented.
Information query
Patent Agency Ranking
0/0